Literature DB >> 18329543

Systemic sclerosis and localized scleroderma in childhood.

Francesco Zulian1.   

Abstract

Juvenile scleroderma syndromes, including the systemic and the localized varieties, represent the third most frequent chronic rheumatic conditions in pediatric rheumatology practice. In children, systemic sclerosis shows a significantly less frequent involvement of all organs, a higher prevalence of arthritis and myositis, and a better outcome than in adults. Recently, new classification criteria were proposed, which help improve patient care by enabling earlier, more definite diagnoses and by standardizing the conduct of clinical trials. Localized scleroderma is the more frequent subtype of scleroderma in childhood. It comprises a group of distinct conditions that involve mainly the skin and subcutaneous tissues. They range from small plaques of fibrosis involving only the skin to diseases causing significant functional deformity with various extracutaneous features.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18329543     DOI: 10.1016/j.rdc.2007.11.004

Source DB:  PubMed          Journal:  Rheum Dis Clin North Am        ISSN: 0889-857X            Impact factor:   2.670


  12 in total

1.  Localised scleroderma en coup de sabre affecting the skin, dentition and bone tissue within craniofacial neural crest fields. Clinical and radiographic study of six patients.

Authors:  S R Lauesen; J Daugaard-Jensen; E F Lauridsen; I Kjær
Journal:  Eur Arch Paediatr Dent       Date:  2019-03-07

2.  [Localized scleroderma (morphea) in childhood].

Authors:  L Weibel
Journal:  Hautarzt       Date:  2012-02       Impact factor: 0.751

3.  Cutaneous Connective Tissue Diseases: Epidemiology, Diagnosis, and Treatment.

Authors:  Bobby Y Reddy; Basil M Hantash
Journal:  Open Dermatol J       Date:  2009-01-01

4.  Linear scleroderma en coup de sabre including abnormal dental development.

Authors:  M Hørberg; S R Lauesen; J Daugaard-Jensen; I Kjær
Journal:  Eur Arch Paediatr Dent       Date:  2014-10-30

5.  Atypical presentation of scleroderma in infancy.

Authors:  Navin Mishra; Devendra Shrestha; Rakesh Babu Poudyal; K C Shiva Raj
Journal:  Rheumatol Int       Date:  2011-02-16       Impact factor: 2.631

6.  Clinical and laboratory profile of juvenile-onset systemic sclerosis in a Brazilian cohort.

Authors:  Percival D Sampaio-Barros; Adriana B Bortoluzzo; Ana Paula T Del Rio; Ana Paula Luppino-Assad; Danieli Co Andrade; João Francisco Marques-Neto
Journal:  J Scleroderma Relat Disord       Date:  2018-04-24

7.  Sonographic evaluation of pediatric localized scleroderma: preliminary disease assessment measures.

Authors:  Suzanne C Li; Melissa S Liebling; Faridali G Ramji; Sven Opitz; Arun Mohanta; Tatiana Kornyat; Shuzhen Zhang; Molly Dempsey-Robertson; Carsten Hamer; Stephanie Edgerton; Jose Jarrin; Mike Malone; Andrea S Doria
Journal:  Pediatr Rheumatol Online J       Date:  2010-04-27       Impact factor: 3.054

8.  Multi-centre national audit of juvenile localised scleroderma: describing current UK practice in disease assessment and management.

Authors:  Hanna Lythgoe; Beverley Almeida; Joshua Bennett; Chandrika Bhat; Amarpal Bilkhu; Mary Brennan; Samundeeswari Deepak; Pamela Dawson; Despina Eleftheriou; Kathryn Harrison; Daniel Hawley; Eleanor Heaf; Valentina Leone; Ema Long; Sarah Maltby; Flora McErlane; Nadia Rafiq; Athimalaipet V Ramanan; Phil Riley; Satyapal Rangaraj; Giulia Varnier; Nick Wilkinson; Clare E Pain
Journal:  Pediatr Rheumatol Online J       Date:  2018-12-18       Impact factor: 3.054

9.  Current treatment strategies: collagen vascular diseases in children.

Authors:  Aparna Palit; Arun C Inamadar
Journal:  Indian J Dermatol       Date:  2012-11       Impact factor: 1.494

10.  A cross-sectional electromyography assessment in linear scleroderma patients.

Authors:  Claudia Saad Magalhães; Taciana de Albuquerque Pedrosa Fernandes; Thiago Dias Fernandes; Luis Antonio de Lima Resende
Journal:  Pediatr Rheumatol Online J       Date:  2014-07-12       Impact factor: 3.054

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.